Anzeige
Mehr »
Login
Freitag, 10.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
100 % Anstieg in zwei Tagen: Das technische Signal, das Wall Streets Bären in Panik versetzt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
208 Leser
Artikel bewerten:
(1)

E Fund Management: 2024 Marks Breakout Year for China's ETF Market with Unprecedented Growth

Finanznachrichten News

GUANGZHOU, China, Jan. 10, 2025 /PRNewswire/ -- China's ETF market demonstrated exceptional performance in 2024, with notable returns and substantial growth in assets under management. According to Wind, the average return of A-share ETFs (excl. ETFs launched in 2024) reached 11.36% for the year by December 31, and the total size of A-share ETF market reached USD 508 billion, a net increase of USD 223 billion from year-begin. Notably, CSI 300 ETF (Code: 510310), ChiNext ETF (Code: 159915), and Star 50 ETF (Code: 588080) managed by E Fund Management ("E Fund"), the largest mutual fund manager in China, ranked among the top ten in asset growth, underlining the company's strong position in the industry.


A Two-Decade Journey of Growth

Since the launch of the first domestic ETF in December 2004, China's ETF market has expanded significantly. This growth is not only marked by an increase in assets but also by an acceleration in ETF issuance. In 2024, 30 fund companies launched 156 new ETFs, with E Fund leading the market by introducing 14 new products - the most among all issuers.

Over the years, the ETF market has evolved from focusing primarily on broad-based indices to offering a diverse range of products across sectors, asset classes, and themes. These innovations have broadened investment opportunities, providing both institutional and retail investors with low-cost, transparent, and flexible tools to achieve their financial goals.

The Push for Low-Cost Investing

In 2024, Chinese fund companies accelerated the trend of reducing management fees, particularly for broad-based ETFs. Leading the charge is E Fund, which has long been a pioneer in promoting cost-efficient investing. As early as 2015, E Fund set a market precedent by lowering the management fee of its flagship CSI 300 ETF (Code: 510310) from 0.5% to 0.2%, and further reduced it to 0.15% in 2019.

E Fund's leadership in low-fee strategy is further exemplified by its extensive product range, nearly 50 ETF products offering the lowest management fee of 0.15%, accounting for 60% of its ETF portfolio.

Shaping the Future of China's ETF Market

With over 80 ETFs under management and total assets exceeding USD 83.7 billion, E Fund continues to innovate by offering a broad range of low-cost, high-efficiency investment solutions.

As China's ETF market evolves and expands, E Fund remains at the forefront, driving innovation and setting new standards for accessibility and efficiency. The rapid growth in 2024 underscores not only the increasing popularity of ETFs but also their critical role in shaping the future of China's investment landscape.

About E Fund

Established in 2001, E Fund Management Co., Ltd. ("E Fund") is a leading comprehensive mutual fund manager in China with over RMB 3.5 trillion (USD 505 billion) under management.* It offers investment solutions to onshore and offshore clients, helping clients achieve long-term sustainable investment performances. E Fund's clients include both individuals and institutions, ranging from central banks, sovereign wealth funds, social security funds, pension funds, insurance and reinsurance companies, to corporates and banks. Long-term oriented, it has been focusing on the investment management business since inception and believes in the power of in-depth research and time in investing. It is a pioneer and leading practitioner in responsible investments in China and is widely recognized as one of the most trusted and outstanding Chinese asset managers.

Source: E Fund. AuM includes subsidiaries. Data as of Sep 30, 2024. FX rate is sourced from PBoC.

Logo - https://mma.prnewswire.com/media/2085383/_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/2024-marks-breakout-year-for-chinas-etf-market-with-unprecedented-growth-302347971.html

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.